You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model

 

Online download statistics by month:

Online download statistics by month: March 2021 to February 2026

AbstractFullPdf
Mar 2021483483141
Apr 2021413414147
May 202116716751
Jun 202118118143
Jul 202114614672
Aug 202116816840
Sep 202111211238
Oct 202110410463
Nov 202112312371
Dec 202112913453
Jan 20228810368
Feb 2022869352
Mar 2022869147
Apr 202211412559
May 20229710847
Jun 20229810235
Jul 2022768235
Aug 202210711644
Sep 2022859156
Oct 202210610942
Nov 2022909659
Dec 202210310347
Jan 2023757524
Feb 2023979840
Mar 202311311751
Apr 2023767939
May 2023757540
Jun 2023838417
Jul 2023899049
Aug 202313313439
Sep 202318318438
Oct 202328729236
Nov 202352852830
Dec 2023636429
Jan 2024555630
Feb 2024848441
Mar 202414614660
Apr 2024939660
May 2024727345
Jun 2024929138
Jul 202411211751
Aug 2024858639
Sep 2024636336
Oct 2024828243
Nov 2024949833
Dec 2024899235
Jan 202513313326
Feb 202513513544
Mar 202510010162
Apr 202511311467
May 202510410551
Jun 2025757926
Jul 2025110
Feb 2026110
Total669368242529